FAIRFIELD, Conn., May 26, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that CTT’s pain therapy medical device will be used by clinical investigators at the Virginia Commonwealth University Massey Cancer Center (Massey) for a Phase II independent clinical study. The study will examine the ability of CTT’s U.S. FDA-cleared device to decrease pain associated with chemotherapy-induced peripheral neuropathy (CIPN).
